Treatment of the refractory angina in the very elderly patients and centenarians

O.A. Yepanchintseva, O.P. Nadorak, Yu.A. Borkhalenko, S.I. Mashkovska, O.J. Zharinov

References

1.  Antzelevitch C, Belardinelli L, Zygmunt AC, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation. 2004;110:904-910.
2. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. New Engl J Medicine. 2008;358:1887-1898.
3. Dobesh PP, Trujillo TC. Ranolazine: A new option in the management of chronic stable angina. Pharmacotherapy. 2007;27(12):1659-1676.
4. Ferrari R, Hearse D. Ischemic Heart Disease & Chronic Heart Failure in the Elderly. Dialogues in Cardiovascular Medicine. 2008;13(1):3-66.
5. Fihn SD, Gardin JM, Abrams J, et al. American College of Cardiology Foundation/American Heart Association Task Force. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):e354-471.
6. Graham MM,  Ghali WA, et al. Survival after coronary revascularization in the elderly. Circulation. 2002;105:2378-2384.
7. Greene RS, Rangel RM, Edwards KL, et al. Ranolazine for the treatment of refractory angina in a veterans population. Cardiovasc Revasc Med. 2012;13:e141.
8. Kumar S, Hall RJ. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists. Drugs Aging. 2003;20(11):805-815.
9. Martínez-Sellés M, García de la Villa B, Cruz-Jentoft A J, et al. Centenarians and their hearts: A prospective registry with comprehensive geriatric assessment, electrocardiogram, echocardiography, and follow-up. Am Heart J. 2015;169:798-805.
10. McGillion M, Arthur HM, Cook A, et al. Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines. Canad J Cardiology. 2012;28:S20-S41.
11. Mukherjee D. Management of refractory angina in the contemporary era. Eur Heart J. 2013;34:2655-2657.
12. Muhlestein JB, Sharon G. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina. Drugs. 2013;13:207-213.
13. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. One year results of the randomized TIME trial. JAMA. 2003;9:1117-1123.
14. Povsic TJ, Broderick S, Anstrom KJ, et al. Predictors of long-term clinical endpoints in patients with refractory angina. J Amer Heart Association. 2015;4:1-12.
15. Rabunal-Rey R, Monte-Secades R, Gomez-Gigirey A, et al. Electrocardiographic abnormalities in centenarians: impact on survival. BMC Geriatrics. 2012;12-15.
16. Wheatley BJ,  Gorsuch JM, et al. Vascular procedures in nonagenarians and centenarians are safe. Amer J Surgery. 2011;201:301-304.
17. Young JW, Melander Jr, Melander S. Evaluating symptoms to improve quality of life in patients with chronic stable angina. Nursing Research and Practice. 2013:1-8.